Stryker to Buy Entellus Medical For $662 Million

Robert W. Baird upgraded shares of Stryker from a "neutral" rating to an "outperform" rating and raised their target price for the stock from $161.00 to $173.00 in a research report on Thursday, November 16th. The stock had a trading volume of 1,090,543 shares, compared to its average volume of 1,181,132.

The directors of Stryker Corp. have declared a fourth-quarter that is 11 percent higher than a year ago.

Stryker Corporation (NYSE:SYK) last posted its quarterly earnings data on Thursday, October 26th.

Shares of Stryker Corporation (NYSE:SYK) have received an average rating of "Hold" from the twenty-five research firms that are now covering the stock, Marketbeat Ratings reports. Stryker had a return on equity of 24.11% and a net margin of 14.67%.

ILLEGAL ACTIVITY NOTICE: "Stryker Corporation (SYK) Given Consensus Rating of "Hold" by Analysts" was reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have issued a buy rating to the company's stock. The business had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.97 billion. Finally, Argus reissued a "buy" rating and issued a $160.00 price target on shares of Stryker in a research note on Tuesday, August 29th.

Shares of Entellus Medical Inc (NASDAQ:ENTL) have been given a consensus recommendation of "Hold" by the nine brokerages that are now covering the firm, reports. The stock was acquired at an average price of $12.24 per share, with a total value of $122,400.00. SunTrust Banks, Inc. reissued a "buy" rating and issued a $161.00 price objective on shares of Stryker Corporation in a research note on Friday. If you are reading this report on another domain, it was illegally copied and republished in violation of US and worldwide copyright & trademark legislation. Following the completion of the transaction, the insider now owns 83,207 shares in the company, valued at approximately $12,925,375.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Several brokerages recently commented on SYK. Corporate insiders own 7.40% of the company's stock. Bank of America Corp DE raised its stake in shares of Entellus Medical by 53.8% in the first quarter. Teachers Advisors LLC raised its stake in Entellus Medical by 17.4% in the first quarter. Global Financial Private Capital LLC bought a new stake in shares of Stryker Corporation in the first quarter worth about $1,851,000. The institutional investor owned 32,094 shares of the medical technology company's stock after selling 1,127 shares during the quarter. The original version of this news story can be read at Teachers Advisors LLC now owns 12,369 shares of the medical technology company's stock worth $171,000 after buying an additional 1,836 shares during the period. Finally, Bruderman Asset Management LLC acquired a new stake in shares of Stryker in the second quarter valued at $150,000. Hedge funds and other institutional investors own 74.97% of the company's stock. "Entellus is a leader in the ENT segment and offers a comprehensive portfolio of products that enable physicians to conveniently and comfortably perform a broad range of ENT procedures, ' stated Timothy J. Scannell, Group President, MedSurg and Neurotechnology".

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Notícias recomendadas

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.